Exploratory Centers for Translational Research on the Clinical Neurobiology of Drug Addiction (P20)

The summary for the Exploratory Centers for Translational Research on the Clinical Neurobiology of Drug Addiction (P20) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Exploratory Centers for Translational Research on the Clinical Neurobiology of Drug Addiction (P20): -Purpose. This solicitation invites applications for the development of Exploratory Translational Research Centers on the clinical neurobiology of drug abuse and addiction.For purposes of this FOA, an Exploratory Translational Research Center is defined as an entity with a strong primary human neurobiology focus in which preclinical research is included to directly inform or provide a mechanistic foundation for the human neuroscience/neurobiological research. -Mechanism of Support. This FOA will use the NIH P20 award mechanism. The P20 is a planning grant mechanism to promote the development of mature translational research centers by the end of the funding period. The focus of these applications should be on the development of appropriate infrastructure, including personnel and resources, and the generation of sufficient high quality data to provide the basis for a mature P50 translational research center application by the end of the funding period.Features that distinguish a P20 from other center grant mechanisms include: (1) Proposed centers must be comprised of at least three, but no more than five, scientific projects; the primary specific aim must propose to conduct human neurobiological research and at least one of the aims must conduct preclinical (non-human) research. (2) Each research project should have the characteristics of a traditional research project grant, although the projects are expected to be smaller in scale than might be proposed for an individual research application. (3) Because one of the goals of this FOA is to foster the development of new collaborations and research teams, such projects, by design, are considered high risk/exploratory and are encouraged. (4) Preliminary data from nascent or as yet formed research collaborations are not expected, evidence of capacity to contribute to the proposed research collaborations, however, is expected. -Funds Available and Anticipated Number of Awards. NIDA intends to commit $3.0 million dollars in FY2009 to fund 2-3 new grants in response to this FOA.